ARTICLE | Clinical News
Medical Marketing preclinical data
October 1, 2007 7:00 AM UTC
In vitro, MMG's lentivirally derived ribozymes suppressed receptors on white blood cells that allow HIV entry for about 90 days. ...
In vitro, MMG's lentivirally derived ribozymes suppressed receptors on white blood cells that allow HIV entry for about 90 days. ...